Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Derived CAR-T for R/R B-Cell Malignancies
NCT03881774Phase 1Unknown
- Sponsor
- Henan Cancer Hospital
- Start
- Feb 2019
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in B-cell leukemia (BCL) and B cell lymphoma, sponsored by Henan Cancer Hospital. Primary endpoint: Occurrence of study related adverse events at 1 year. Status: unknown.
02
Conditions
B-cell leukemia (BCL)B cell lymphoma
Beyond the preview
Go deeper on NCT03881774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03881774.